Adam Stefanski

4PUBLICATIONS

23CO-AUTHORS

Isotope geochemistryExercise physiologyMedical biochemistry - lipidsPharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 24, 2026

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials.

|Jun 23, 2025

Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide.

Bruno Linetzky, Naveed Sattar, Subodh Verma

|Feb 25, 2025

Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.

Michelle Look, Julia P Dunn, Robert F Kushner

|Feb 05, 2024

Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m<sup>2</sup>: SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy.

James A de Lemos, Bruno Linetzky, Carel W le Roux

Pageof 1

Frequent Collaborators

Bruno Linetzky

James A de Lemos

Carel W le Roux

Luke J Laffin

Wanpen Vongpatanasin

Ludi Fan

Mathijs C Bunck

Michelle Look

Julia P Dunn

Robert F Kushner

Frequent Collaborators

Bruno Linetzky

James A de Lemos

Carel W le Roux

Luke J Laffin